Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(13%)
Results Posted
17%(1 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_4
1
7%
Ph not_applicable
4
27%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Completed6
Terminated2
Recruiting2
Not yet recruiting2
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

terminated213%
unknown17%
completed640%
recruiting213%
withdrawn17%
enrolling_by_invitation17%
not_yet_recruiting213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT07470580Not Applicable

Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension

Not Yet Recruiting
NCT07181213Not Applicable

Genetic Predisposition to High Blood Pressure

Enrolling By Invitation
NCT07268222Phase 4

Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS)

Recruiting
NCT07200245

Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors

Not Yet Recruiting
NCT04127552

Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations

Recruiting
NCT02945904

IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism

Completed
NCT06062082

Intraoperative Hemodynamic Instability During Unilateral Adrenalectomy for Pheochromocytoma

Completed
NCT06697652

Readmission After Adrenalectomy

Completed
NCT04556279

Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.

Withdrawn
NCT01246739Not Applicable

Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome

Terminated
NCT05888753

Textbook Outcome in Adrenal Neoplasms

Completed
NCT03174847

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

Completed
NCT02362308

Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

Completed
NCT04860180Not Applicable

Effect of Surgical or Conservative Approach in Patients With Adrenal Incidentalomas

Unknown
NCT02001051Phase 2

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Terminated

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15